arznei-telegramm & atd

Now in its 56th year, the arznei-telegramm® (a-t) informs medical professionals about the benefits and risks of medicines - neutral and independent, without advertising and financed exclusively through subscriptions. It is published monthly and provides current practical recommendations with a special focus on safety and benefits relevant to patients.

The atd drug database (additional license required) evaluates in detail more than 2,000 active ingredients and therefore around 18,000 drugs. It lists their prices, indications, contraindications, side effects, interactions and pharmacokinetics and links to over 16,000 additional sources. The drug database is updated and supplemented monthly, for example with new medications.

Non-subscribers can view all issues of the arznei-telegramm® except for the years since 2015, from which selected articles are freely accessible.

As a subscriber you have full access (except for a print subscription without online access).
• to all arznei-telegramm® texts from 1990 to the current edition
• to the e a-t (additional texts online)
• to the blitz-a-t (sent by email) for important things “in between”
• to the NETWORK ADR database.